Literature DB >> 28965306

Current Treatment Options: Vestibular Migraine.

Clinton G Lauritsen1, Michael J Marmura2.   

Abstract

OPINION STATEMENT: Vestibular migraine (VM) is a disorder with a spectrum of clinical presentations and among the most common causes of chronic vestibular symptoms. Some present with attacks before or during typical migraine, but many others have fluctuating or daily symptoms. While the symptoms and pathogenesis of vestibular migraine may have elements of both central and peripheral disorders, hearing loss should be absent. VM typically worsens with activity and head movements in general, and encompasses symptoms of vertigo, disequilibrium, or imbalance. While it is possible to confuse other disorders such as Meniere's disease with migraine, it is worth making the diagnosis of vestibular migraine on clinical grounds after ruling out other possible causes. For acute attack treatment, migraine-specific medications such as triptans may be effective. In patients with frequent or disabling attacks, preventive treatment is essential. Vestibular rehabilitation may be helpful as well as medications used for migraine prevention such as including propranolol, venlafaxine, topiramate, and amitriptyline. For refractory patients, use of acetazolamide or lamotrigine may be reasonable.

Entities:  

Keywords:  Dizziness; Migraine-associated vertigo; Migrainous vertigo; Vertiginous migraine; Vertigo; Vestibular migraine (VM)

Year:  2017        PMID: 28965306     DOI: 10.1007/s11940-017-0476-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  61 in total

1.  Episodic vertigo related to migraine (90 cases): vestibular migraine?

Authors:  M Dieterich; T Brandt
Journal:  J Neurol       Date:  1999-10       Impact factor: 4.849

2.  Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study.

Authors:  R Teggi; B Colombo; O Gatti; G Comi; M Bussi
Journal:  Neurol Sci       Date:  2015-06-03       Impact factor: 3.307

3.  [An analysis of clinical features of 226 vestibular migraine patients].

Authors:  Feng Qiu; Xin Huang; Xiaofeng Wang; Jianguo Liu; Xiaokun Qi
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2014-12

Review 4.  Late-life migraine accompaniments: A narrative review.

Authors:  Kiratikorn Vongvaivanich; Paweena Lertakyamanee; Stephen D Silberstein; David W Dodick
Journal:  Cephalalgia       Date:  2014-12-12       Impact factor: 6.292

5.  Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings.

Authors:  Jung H Shin; Yu K Kim; Hyo-Jung Kim; Ji-Soo Kim
Journal:  Cephalalgia       Date:  2013-08-05       Impact factor: 6.292

Review 6.  Overview of the International Classification of Vestibular Disorders.

Authors:  Alexandre R Bisdorff; Jeffrey P Staab; David E Newman-Toker
Journal:  Neurol Clin       Date:  2015-08       Impact factor: 3.806

7.  [Clinical characteristics of 100 vestibular migraine cases].

Authors:  Jincheng Chen; Degui Gong; Shuhe Cai; Ziming Wu; Xingjian Lin; Xiaoyan Ma; Liqun Yu
Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2016-03

Review 8.  Topiramate in migraine progression.

Authors:  Luigi Ruiz; Delfina Ferrandi
Journal:  J Headache Pain       Date:  2009-10-17       Impact factor: 7.277

9.  Referral and final diagnoses of patients assessed in an academic vertigo center.

Authors:  Rebekka Geser; Dominik Straumann
Journal:  Front Neurol       Date:  2012-11-28       Impact factor: 4.003

10.  Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study.

Authors:  Foad Taghdiri; Mansoureh Togha; Soodeh Razeghi Jahromi; Farshid Refaeian
Journal:  Springerplus       Date:  2014-05-07
View more
  8 in total

1.  Factors implicated in response to treatment/prognosis of vestibular migraine.

Authors:  James R Dornhoffer; Yuan F Liu; Lane Donaldson; Habib G Rizk
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-05-24       Impact factor: 2.503

Review 2.  Effects of Vestibular Rehabilitation in the Management of a Vestibular Migraine: A Review.

Authors:  Ahmad H Alghadir; Shahnawaz Anwer
Journal:  Front Neurol       Date:  2018-06-12       Impact factor: 4.003

3.  Subdiagnosis, but not presence of vestibular symptoms, predicts balance impairment in migraine patients - a cross sectional study.

Authors:  Letícia Zorzin; Gabriela F Carvalho; Jens Kreitewolf; Roberto Teggi; Carina F Pinheiro; Jéssica R Moreira; Fabíola Dach; Débora Bevilaqua-Grossi
Journal:  J Headache Pain       Date:  2020-05-24       Impact factor: 7.277

4.  Clinical significance of serum sex hormones in postmenopausal women with vestibular migraine: potential role of estradiol.

Authors:  Bo Tang; Xiaojun Yu; Wei Jiang; Chuang Zhang; Tao Zhan; Yuqin He
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

5.  The University of Kansas Health System Outpatient Clinical Concussion Comprehensive Protocol: An Interdisciplinary Approach.

Authors:  Maria Davenport; Bill Condon; Claude Lamoureux; Jamie L Phipps Johnson; Jamie Chen; Michael A Rippee; Jennifer Zentz
Journal:  Health Serv Insights       Date:  2022-08-23

6.  Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG).

Authors:  Otmar Bayer; Christine Adrion; Amani Al Tawil; Ulrich Mansmann; Michael Strupp
Journal:  Trials       Date:  2019-12-30       Impact factor: 2.279

Review 7.  The Treatment of Vestibular Migraine: A Narrative Review.

Authors:  Youjin Shen; Xiaokun Qi; Tingyu Wan
Journal:  Ann Indian Acad Neurol       Date:  2020-02-11       Impact factor: 1.383

Review 8.  Care Gaps and Recommendations in Vestibular Migraine: An Expert Panel Summit.

Authors:  Monica P Mallampalli; Habib G Rizk; Amir Kheradmand; Shin C Beh; Mehdi Abouzari; Alaina M Bassett; James Buskirk; Claire E J Ceriani; Matthew G Crowson; Hamid Djalilian; Joel A Goebel; Jeffery J Kuhn; Anne E Luebke; Marco Mandalà; Magdalena Nowaczewska; Nicole Spare; Roberto Teggi; Maurizio Versino; Hsiangkuo Yuan; Ashley Zaleski-King; Michael Teixido; Frederick Godley
Journal:  Front Neurol       Date:  2022-01-03       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.